Concepedia

Marc Blouin

MB

Statistics

Publications

16

Citations

948

H-Index

15

Active since

1990

Affiliations

Merck Canada Inc. (Canada)(Current)

Merck & Co., Inc., Rahway, NJ, USA (United States)

Université de Montréal

Marc Blouin is an author at Merck Canada Inc. (Canada) specializing in medicinal chemistry, pharmacology, and drug discovery.

Publications per year

1990–2013

16

Publications

16

Quinolines as potent 5-lipoxygenase inhibitors: Synthesis and biological profile of L-746,530

Daniel Dubé, Marc Blouin, Christine Brideau et al. · Bioorganic & Medicinal Chemistry Letters · 1998 · 272 citations · Full text

, , +11

Discovery of MK-1439, an orally bioavailable non-nucleoside reverse transcriptase inhibitor potent against a wide range of resistant mutant HIV viruses

Bernard Côté, Jason D. Burch, Ernest Asante‐Appiah et al. · Bioorganic & Medicinal Chemistry Letters · 2013 · 101 citations

, , +14

The Discovery of Setileuton, a Potent and Selective 5-Lipoxygenase Inhibitor

Yves Ducharme, Marc Blouin, Christine Brideau et al. · ACS Medicinal Chemistry Letters · 2010 · 80 citations

, , +15

Optimization of a Tertiary Alcohol Series of Phosphodiesterase-4 (PDE4) Inhibitors:  Structure−Activity Relationship Related to PDE4 Inhibition and Human Ether-a-go-go Related Gene Potassium Channel Binding Affinity

Richard W. Friesen, Yves Ducharme, Richard G. Ball et al. · Journal of Medicinal Chemistry · 2003 · 66 citations · Full text

, , +17

A New Method for the Preparation of Aryl Vinyl Ethers

Marc Blouin, Richard Frenette · The Journal of Organic Chemistry · 2001 · 59 citations

, , +5

1–5 of 16